论文部分内容阅读
目的:探讨经皮冠状动脉介入治疗发生(percutaneous coronary intervention,PCI)腹膜后血肿(Retroperitoneal hematoma RPH)的情况。方法:2006年1月至2010年11月连续收集吉林省20家三甲教学医院行PCI治疗的8 646例患者资料,RPH发生32例,回顾性研究RPH发生的相关因素,并进行统计分析。结果:比较病人的基本特征、临床特征和院内疗效,得出PCI后发生RPH的诱发危险因素、处理和死亡预期。结论:RPH是PCI一种少见但严重的并发症,识别RPH发生的诱发危险因素和调整治疗策略,具有重要的临床意义。
Objective: To investigate the situation of percutaneous coronary intervention (PCI) retroperitoneal hematoma RPH. Methods: From January 2006 to November 2010, 8 646 patients undergoing PCI in 20 Shatin Jiaoyao Teaching Hospitals in Jilin Province were continuously collected. 32 cases of RPH occurred and the related factors of RPH were retrospectively studied and statistically analyzed. Results: The basic characteristics, clinical characteristics and hospital efficacy were compared. The risk factors, treatment and death expectation of RPH after PCI were obtained. Conclusion: RPH is a rare but serious complication of PCI. It has important clinical significance to identify the risk factors of RPH and to adjust the treatment strategy.